News

Researchers at Baylor College of Medicine and their collaborators tested a novel approach to restore normal heart function in a mouse model of myotonic dystrophy type 1.

Researchers discovered that Zika virus constructs nanotubes to transport infection across the placental barrier undetected. The viral protein NS1 triggers this process, allowing Zika to spread while evading immune defenses.

A National Institutes of Health (NIH)-sponsored clinical trial of a candidate vaccine to prevent Lassa fever has begun enrolling participants at the University of Maryland School of Medicine, Baltimore.

Researchers have developed pig retinal organoids to understand how stem cell-derived photoreceptor cells work as a therapeutic.

Researchers from the Institute of Science Tokyo have developed CeSPIACE, a peptide inhibitor that blocks SARS-CoV-2 from binding to host cell receptors. Unlike some existing treatments, CeSPIACE works against many variants.

Researchers at MIT have devised a simplified process to convert a skin cell directly into a neuron. The new method bypasses the stem cell stage and can produce more than 10 neurons from a single skin cell.

Natural products have become a mainstay in modern society and are used for numerous applications such as medicine and pesticides. Researchers have now developed a new method to accelerate bioactive natural product discovery.

A recent study by Tokyo’s Waseda University, reports a novel imaging technique that allows direct and highly sensitive tracking of drugs inside the body using gold nanoparticles.

New research suggests that receiving multiple doses of a vaccine in the same limb leads to faster antibody development, an important strategy for providing immunity as quickly as possible during a pandemic or disease outbreak.

Tel Aviv University researchers used CRISPR to cut the SOX2 gene from head and neck cancer cells, eliminating 50% of tumors in mice. The study highlights CRISPR’s potential for cancer treatment.